Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Lynk Pharmaceuticals Completes Series C2 Financing Round, with Total C Round Funding of 322 Million RMB 2023-09-21 08:00
Everest Medicines Enters into Collaboration and License Agreement with Kezar Life Sciences to Develop and Commercialize Zetomipzomib in Greater China and other Asian Markets 2023-09-21 07:05
European Commission Approves Menarini Group's ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation 2023-09-20 23:27
Hepagene Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for HPG7233 THR Beta Agonist 2023-09-20 22:00
Taiwan's Premier Health Brand Unveils Best Quality Pineapple Enzyme for Digestive Health 2023-09-20 21:00
Double Honors: Sanyou Bio Earns "Most Trusted Biopharmaceutical CXO Partner" and "Most Influential Partner of the Year" Awards 2023-09-20 20:00
WuXi XDC Launches New Commercial Manufacturing Facilities 2023-09-20 18:51
The First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint 2023-09-20 15:52
AffaMed Therapeutics Announces First Patient Treated in Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery 2023-09-20 09:00
Everest Medicines Announces China Center for Drug Evaluation of NMPA Recommends Priority Review for Cefepime-Taniborbactam for the Treatment of Complicated Urinary Tract Infections, including Pyelonephritis 2023-09-20 08:26
Cerecin strengthens position in neurometabolism with addition to pipeline 2023-09-19 19:39
Caliway Announces the Completion of Subject Recruitment in the CBL-0201EFP Phase 2-stage 2 Study Evaluating the CBL-514 in Cellulite Treatment 2023-09-19 11:16
ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility 2023-09-19 09:16
Canton Biologics Completes Over 300 Million Yuan Series C Financing, Led by SDIC Venture Capital 2023-09-18 18:43
Biosyngen received the Asia Pacific Cell & Gene Therapy Excellence Awards (APCGTEA) 2023 2023-09-18 17:53
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance 2023-09-18 07:57
New drug class prevents key ageing mechanism in organ transplants 2023-09-18 06:01
YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection 2023-09-15 20:30
Neoss® Group has launched a new wireless intraoral scanner, NeoScan™ 2000 2023-09-15 16:00
Green Leadership Award Presented to Chugai Pharma Taiwan at the Asia Responsible Enterprise Awards 2023 2023-09-15 11:37
1 79 80 81 82 83 413